skip to main content
Language:
Did you mean: mattos maria v?
Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Material Type:
Article 		Add to e-Shelf

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)

Palumbo, Antonio ; Bringhen, Sara ; Ludwig, Heinz ; Dimopoulos, Meletios A. ; Bladé, Joan ; Mateos, Maria V. ; Rosiñol, Laura ; Boccadoro, Mario ; Cavo, Michele ; Lokhorst, Henk ; Zweegman, Sonja ; Terpos, Evangelos ; Davies, Faith ; Driessen, Christoph ; Gimsing, Peter ; Gramatzki, Martin ; Hàjek, Roman ; Johnsen, Hans E. ; Leal Da Costa, Fernando ; Sezer, Orhan ; Spencer, Andrew ; Beksac, Meral ; Morgan, Gareth ; Einsele, Hermann ; San Miguel, Jesus F. ; Sonneveld, Pieter

Blood, 2011-10, Vol.118 (17), p.4519-4529 [Peer Reviewed Journal]

Washington, DC: Elsevier Inc

Full text available

Citations Cited by
2
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
Material Type:
Article 		Add to e-Shelf

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Paiva, Bruno ; Vidriales, Maria-Belén ; Cerveró, Jorge ; Mateo, Gema ; Pérez, Jose J. ; Montalbán, Maria A. ; Sureda, Anna ; Montejano, Laura ; Gutiérrez, Norma C. ; de Coca, Alfonso García ; de las Heras, Natalia ; Mateos, Maria V. ; López-Berges, Maria C. ; García-Boyero, Raimundo ; Galende, Josefina ; Hernández, Jose ; Palomera, Luis ; Carrera, Dolores ; Martínez, Rafael ; de la Rubia, Javier ; Martín, Alejandro ; Bladé, Joan ; Lahuerta, Juan J. ; Orfao, Alberto ; San Miguel, Jesús F.

Blood, 2008-11, Vol.112 (10), p.4017-4023 [Peer Reviewed Journal]

United States: Elsevier Inc

Full text available

Citations Cited by
3
Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy
Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy
Material Type:
Article 		Add to e-Shelf

Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy

MATEO, Gema ; MONTALBDN, M. Angeles ; DE LA RUBIA, Javier ; DIAZ-MEDIAVILLA, Joaquin ; SUREDA, Anna ; RIBERA, José M ; OJANGUREN, José M ; DE ARRIBA, Felipe ; PALOMERA, Luis ; TEROL, Maria J ; ORFAO, Alberto ; SAN MIGUEL, Jesus F ; VIDRIALES, Maria-Belen ; LAHUERTA, Juan J ; MATEOS, Maria V ; GUTIERREZ, Norma ; ROSINOL, Laura ; MONTEJANO, Laura ; BLADE, Joan ; MARTINEZ, Rafael

Journal of clinical oncology, 2008-06, Vol.26 (16), p.2737-2744 [Peer Reviewed Journal]

Baltimore, MD: American Society of Clinical Oncology

Full text available

Citations Cited by
4
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Material Type:
Article 		Add to e-Shelf

Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

Mateos, Maria V ; Gavriatopoulou, Maria ; Facon, Thierry ; Auner, Holger W ; Leleu, Xavier ; Hájek, Roman ; Dimopoulos, Meletios A ; Delimpasi, Sosana ; Simonova, Maryana ; Špička, Ivan ; Pour, Ludĕk ; Kriachok, Iryna ; Pylypenko, Halyna ; Doronin, Vadim ; Usenko, Ganna ; Benjamin, Reuben ; Dolai, Tuphan K ; Sinha, Dinesh K ; Venner, Christopher P ; Garg, Mamta ; Stevens, Don A ; Quach, Hang ; Jagannath, Sundar ; Moreau, Philippe ; Levy, Moshe ; Badros, Ashraf Z ; Anderson, Jr, Larry D ; Bahlis, Nizar J ; Cavo, Michele ; Chai, Yi ; Jeha, Jacqueline ; Arazy, Melina ; Shah, Jatin ; Shacham, Sharon ; Kauffman, Michael G ; Richardson, Paul G ; Grosicki, Sebastian

Journal of hematology and oncology, 2021-04, Vol.14 (1), p.59-59, Article 59 [Peer Reviewed Journal]

England: BioMed Central Ltd

Full text available

Citations Cited by
5
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma
Material Type:
Article 		Add to e-Shelf

A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma

Jiménez, Cristina ; Jara-Acevedo, María ; Corchete, Luis A ; Castillo, David ; Ordóñez, Gonzalo R ; Sarasquete, María E ; Puig, Noemí ; Martínez-López, Joaquín ; Prieto-Conde, María I ; García-Álvarez, María ; Chillón, María C ; Balanzategui, Ana ; Alcoceba, Miguel ; Oriol, Albert ; Rosiñol, Laura ; Palomera, Luis ; Teruel, Ana I ; Lahuerta, Juan J ; Bladé, Joan ; Mateos, María V ; Orfão, Alberto ; San Miguel, Jesús F ; González, Marcos ; Gutiérrez, Norma C ; García-Sanz, Ramón

The Journal of molecular diagnostics : JMD, 2017, Vol.19 (1), p.99-106 [Peer Reviewed Journal]

United States: Elsevier Inc

Full text available

Citations Cited by
6
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma
Material Type:
Article 		Add to e-Shelf

P53 deletion may drive the clinical evolution and treatment response in multiple myeloma

López‐Anglada, Lucía ; Gutiérrez, Norma C. ; García, Juan L. ; Mateos, María V. ; Flores, Teresa ; San Miguel, Jesús F.

European journal of haematology, 2010-04, Vol.84 (4), p.359-361 [Peer Reviewed Journal]

Oxford, UK: Blackwell Publishing Ltd

Full text available

Citations Cited by
7
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
Material Type:
Article 		Add to e-Shelf

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Grosicki, Sebastian ; Simonova, Maryana ; Spicka, Ivan ; Pour, Ludek ; Kriachok, Iryrna ; Gavriatopoulou, Maria ; Pylypenko, Halyna ; Auner, Holger W ; Leleu, Xavier ; Doronin, Vadim ; Usenko, Ganna ; Bahlis, Nizar J ; Hajek, Roman ; Benjamin, Reuben ; Dolai, Tuphan K ; Sinha, Dinesh K ; Venner, Christopher P ; Garg, Mamta ; Gironella, Mercedes ; Jurczyszyn, Artur ; Robak, Pawel ; Galli, Monica ; Wallington-Beddoe, Craig ; Radinoff, Atanas ; Salogub, Galina ; Stevens, Don A ; Basu, Supratik ; Liberati, Anna M ; Quach, Hang ; Goranova-Marinova, Vesselina S ; Bila, Jelena ; Katodritou, Eirini ; Oliynyk, Hanna ; Korenkova, Sybiryna ; Kumar, Jeevan ; Jagannath, Sundar ; Moreau, Phillipe ; Levy, Moshe ; White, Darrell ; Gatt, Moshe E ; Facon, Thierry ; Mateos, Maria V ; Cavo, Michele ; Reece, Donna ; Anderson, Larry D ; Saint-Martin, Jean-Richard ; Jeha, Jacqueline ; Joshi, Anita A ; Chai, Yi ; Li, Lingling ; Peddagali, Vishnuvardhan ; Arazy, Melina ; Shah, Jatin ; Shacham, Sharon ; Kauffman, Michael G ; Dimopoulos, Meletios A ; Richardson, Paul G ; Delimpasi, Sosana

The Lancet (British edition), 2020-11, Vol.396 (10262), p.1563-1573 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available

Citations Cited by
8
Plasma Cell Leukemia — Facts and Controversies: More Questions than Answers?
Plasma Cell Leukemia — Facts and Controversies: More Questions than Answers?
Material Type:
Article 		Add to e-Shelf

Plasma Cell Leukemia — Facts and Controversies: More Questions than Answers?

Suska, Anna ; Vesole, David H. ; Castillo, Jorge J. ; Kumar, Shaji K. ; Parameswaran, Hari ; Mateos, Maria V. ; Facon, Thierry ; Gozzetti, Alessandro ; Mikala, Gabor ; Szostek, Marta ; Mikhael, Joseph ; Hajek, Roman ; Terpos, Evangelos ; Jurczyszyn, Artur

Clinical hematology international, 2020, Vol.2 (4), p.133-142 [Peer Reviewed Journal]

Dordrecht: Springer Netherlands

Full text available

Citations Cited by
9
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)
Material Type:
Article 		Add to e-Shelf

BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)

Santamaría, Carlos ; Chillón, María C ; García-Sanz, Ramón ; Pérez, Cristina ; Caballero, María D ; Mateos, María V ; Ramos, Fernando ; de Coca, Alfonso García ; Alonso, José M ; Giraldo, Pilar ; Bernal, Teresa ; Queizán, José A ; Rodríguez, Juan N ; Puig, Noemí ; Balanzategui, Ana ; Sarasquete, María E ; Alcoceba, Miguel ; Díaz-Mediavilla, Joaquín ; San Miguel, Jesús ; González, Marcos

Annals of hematology, 2010-05, Vol.89 (5), p.453-458 [Peer Reviewed Journal]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Full text available

Citations Cited by
10
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Material Type:
Article 		Add to e-Shelf

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

Palumbo, Antonio ; Chanan-Khan, Asher ; Weisel, Katja ; Nooka, Ajay K ; Masszi, Tamas ; Beksac, Meral ; Spicka, Ivan ; Hungria, Vania ; Munder, Markus ; Mateos, Maria V ; Mark, Tomer M ; Qi, Ming ; Schecter, Jordan ; Amin, Himal ; Qin, Xiang ; Deraedt, William ; Ahmadi, Tahamtan ; Spencer, Andrew ; Sonneveld, Pieter

The New England journal of medicine, 2016-08, Vol.375 (8), p.754-766 [Peer Reviewed Journal]

United States: Massachusetts Medical Society

Full text available

Citations Cited by
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Creation Date 

From To
Refine
  1. Before1959  (311)
  2. 1959To1974  (328)
  3. 1975To1990  (379)
  4. 1991To2007  (2,558)
  5. After 2007  (21,950)
  6. More options open sub menu

Language 

  1. English  (19,575)
  2. Spanish  (7,597)
  3. Portuguese  (2,921)
  4. Japanese  (1,185)
  5. Catalan  (110)
  6. German  (100)
  7. French  (52)
  8. Italian  (24)
  9. Norwegian  (15)
  10. Czech  (8)
  11. Polish  (8)
  12. Slovak  (7)
  13. Russian  (6)
  14. Gallegan  (4)
  15. Romanian  (3)
  16. Slovenian  (3)
  17. Persian  (3)
  18. Turkish  (2)
  19. Afrikaans  (2)
  20. Undetermined  (1)
  21. Basque  (1)
  22. More options open sub menu

Suggested New Searches

Ignore my query and look for everything

by this author/creator:

  1. Mateos, J
  2. Mateos, E
  3. Silva, M
  4. Souza, L
  5. Mateos, S

on this subject:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Physical Sciences
  5. Female

  • Implemented by: ABCD-USP USP   Social Network Logos: Freepik

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far